Vanhoutte PM - Search Results

1

International Union of Pharmacology nomenclature of endothelin receptors.

Masaki T, Vane JR, Vanhoutte PM. Masaki T, et al. Among authors: vanhoutte pm. Pharmacol Rev. 1994 Jun;46(2):137-42. Pharmacol Rev. 1994. PMID: 7938163 Review. No abstract available.

2

Receptor classification and nomenclature: the revolution and the resolution.

Humphrey P, Spedding M, Vanhoutte P. Humphrey P, et al. Trends Pharmacol Sci. 1994 Jul;15(7):203-4. doi: 10.1016/0165-6147(94)90311-5. Trends Pharmacol Sci. 1994. PMID: 7940979 No abstract available.

3

Channel nomenclature: IUPHAR recommendations.

Spedding M, Vanhoutte PM. Spedding M, et al. Among authors: vanhoutte pm. Trends Pharmacol Sci. 1993 Dec;14(12):435-6. doi: 10.1016/0165-6147(93)90183-k. Trends Pharmacol Sci. 1993. PMID: 8122321 No abstract available.

4

International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.

Vanhoutte PM, Barnard EA, Cosmides GJ, Humphrey PP, Spedding M, Godfraind T. Vanhoutte PM, et al. Pharmacol Rev. 1994 Jun;46(2):111-6. Pharmacol Rev. 1994. PMID: 7938161 No abstract available.

5

X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.

Vanhoutte PM, Humphrey PP, Spedding M. Vanhoutte PM, et al. Pharmacol Rev. 1996 Mar;48(1):1-2. Pharmacol Rev. 1996. PMID: 8685244 No abstract available.

6

Nomenclature of calcium channels and channel modulators: IUPHAR classification.

Spedding M, Vanhoutte PM. Spedding M, et al. Among authors: vanhoutte pm. J Cardiovasc Pharmacol. 1993 Dec;22(6):906. doi: 10.1097/00005344-199312000-00020. J Cardiovasc Pharmacol. 1993. PMID: 7509912 No abstract available.

7

International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease.

Opie LH, Buhler FR, Fleckenstein A, Hansson L, Harrison DC, Poole-Wilson PA, Schwartz A, Vanhoutte PM, Braunwald E, Nayler WG, et al. Opie LH, et al. Among authors: vanhoutte pm. Am J Cardiol. 1987 Sep 1;60(7):630-2. doi: 10.1016/0002-9149(87)90318-3. Am J Cardiol. 1987. PMID: 3630947 No abstract available.

8

IUPHAR guidelines for classification of new receptor-subtypes.

Vanhoutte PM, Spedding M. Vanhoutte PM, et al. Int J Clin Pharmacol Ther. 1995 Aug;33(8):478. Int J Clin Pharmacol Ther. 1995. PMID: 8556229 No abstract available.

9

TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies.

Akhmedov A, Crucet M, Simic B, Kraler S, Bonetti NR, Ospelt C, Distler O, Ciurea A, Liberale L, Jauhiainen M, Metso J, Miranda M, Cydecian R, Schwarz L, Fehr V, Zilinyi R, Amrollahi-Sharifabadi M, Ntari L, Karagianni N, Ruschitzka F, Laaksonen R, Vanhoutte PM, Kollias G, Camici GG, Lüscher TF. Akhmedov A, et al. Among authors: vanhoutte pm. Cardiovasc Res. 2021 Jan 23:cvab005. doi: 10.1093/cvr/cvab005. Online ahead of print. Cardiovasc Res. 2021. PMID: 33483748

10

Natriuretic peptides relax human intrarenal arteries through natriuretic peptide receptor type-A recapitulated by soluble guanylyl cyclase agonists.

Frees A, Assersen KB, Jensen M, Hansen PBL, Vanhoutte PM, Madsen K, Federlein A, Lund L, Toft A, Jensen BL. Frees A, et al. Among authors: vanhoutte pm. Acta Physiol (Oxf). 2021 Mar;231(3):e13565. doi: 10.1111/apha.13565. Epub 2020 Nov 5. Acta Physiol (Oxf). 2021. PMID: 33010104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results